Fanjun Cheng
Impact in
- Genetics top 10%
- Mesenchymal stem cell research
- Chronic Lymphocytic Leukemia Research
-
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 12
- Mesenchymal stem cell research 6
- Chronic Lymphocytic Leukemia Research 6
- Hematology 11
- Chronic Myeloid Leukemia Treatments 7
- Acute Myeloid Leukemia Research 5
- Co-authors
- Xiaojian Zhu (6 shared papers)Ping Zou (8 shared papers)Liling Zhang (1 shared paper)Zhaodong Zhong (6 shared papers)Na Jin (1 shared paper)Yong You (6 shared papers)Bin Fang (1 shared paper)An‐Yuan Guo (4 shared papers)
- Journals
- Scientific Reports (2 papers)Journal of Cellular Biochemistry (1 paper)Stem Cells Translational Medicine (1 paper)OncoTargets and Therapy (1 paper)Epidemiology and Infection (1 paper)
- Partner nations
- China
In The Last Decade
Fanjun Cheng
26 papers receiving 333 citations
Peers
Comparison fields: 5 of 68
- Genetics 83
- Hematology 69
- Cancer Research 66
- Oncology 98
- Molecular Biology 172
Countries citing papers authored by Fanjun Cheng
This map shows the geographic impact of Fanjun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanjun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanjun Cheng more than expected).
Fields of papers citing papers by Fanjun Cheng
This network shows the impact of papers produced by Fanjun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanjun Cheng. The network helps show where Fanjun Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Fanjun Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 81 | |
| 2 | 2016 | 48 | |
| 3 | 2018 | 41 | |
| 4 | 2010 | 32 | |
| 5 | 2003 | 18 | |
| 6 | 2008 | 18 | |
| 7 | 2021 | 13 | |
| 8 | 2022 | 10 | |
| 9 | 2014 | 10 | |
| 10 | 2019 | 9 | |
| 11 | 2019 | 9 | |
| 12 | 2019 | 9 | |
| 13 | 2016 | 6 | |
| 14 | [The growth characteristics of mesenchymal stem/progenitor cells in human umbilical cord blood]. | 2003 | 6 |
| 15 | 2023 | 5 | |
| 16 | 2010 | 4 | |
| 17 | [The effect of recombinant human erythropoietin on the migration of bone marrow derived mesenchymal stem cells in vitro]. | 2008 | 4 |
| 18 | 2020 | 3 | |
| 19 | 2021 | 2 | |
| 20 | 2019 | 2 |
About Fanjun Cheng
Fanjun Cheng is a scholar working on Genetics, Hematology, Oncology, Molecular Biology and Cancer Research, having authored 27 papers that have together received 338 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (7 papers), Mesenchymal stem cell research (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Acute Myeloid Leukemia Research (5 papers), HER2/EGFR in Cancer Research (3 papers), Retinoids in leukemia and cellular processes (2 papers), Cancer Cells and Metastasis (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Genetics (83 citations), Hematology (69 citations), Cancer Research (66 citations), Oncology (98 citations) and Molecular Biology (172 citations). Fanjun Cheng has collaborated with scholars based in China. Frequent co-authors include Xiaojian Zhu, Ping Zou, Liling Zhang, Zhaodong Zhong, Na Jin, Yong You, Bin Fang, An‐Yuan Guo, Weilong Chang and Wei Liu. Their work appears in journals such as Scientific Reports, Journal of Cellular Biochemistry, Stem Cells Translational Medicine, OncoTargets and Therapy and Epidemiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.